Your browser doesn't support javascript.
loading
EDP-305 in patients with NASH: A phase II double-blind placebo-controlled dose-ranging study.
Ratziu, Vlad; Rinella, Mary E; Neuschwander-Tetri, Brent A; Lawitz, Eric; Denham, Douglas; Kayali, Zeid; Sheikh, Aasim; Kowdley, Kris V; Desta, Taddese; Elkhashab, Magdy; DeGrauw, Jeffery; Goodwin, Bryan; Ahmad, Alaa; Adda, Nathalie.
Afiliação
  • Ratziu V; Sorbonne Université, ICAN, Hospital Pitié-Salpêtrière, INSERM UMRS 1138 CRC, Paris, France.
  • Rinella ME; Northwestern University Feinberg School of Medicine, Chicago, IL, United States.
  • Neuschwander-Tetri BA; Saint Louis University School of Medicine, St. Louis, MO, United States.
  • Lawitz E; Texas Liver Institute, San Antonio, TX United States.
  • Denham D; Clinical Trials of Texas, Inc., San Antonio, TX, United States.
  • Kayali Z; Inland Empire Liver Foundation, Rialto, CA, United States.
  • Sheikh A; GI Specialists of Georgia, Marietta, GA United States.
  • Kowdley KV; Liver Institute Northwest and Elson S. Floyd College of Medicine, Washington State University, Seattle, WA, United States.
  • Desta T; Precision Research Institute, San Diego, CA, United States.
  • Elkhashab M; Toronto Liver Center, Toronto, Ontario, Canada.
  • DeGrauw J; Synexus - Wasatch Peak Family Practice, Layton, UT, United States.
  • Goodwin B; Enanta Pharmaceuticals, Inc, Watertown, MA, United States.
  • Ahmad A; Enanta Pharmaceuticals, Inc, Watertown, MA, United States.
  • Adda N; Enanta Pharmaceuticals, Inc, Watertown, MA, United States. Electronic address: nadda@enanta.com.
J Hepatol ; 76(3): 506-517, 2022 03.
Article em En | MEDLINE | ID: mdl-34740705

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esteroides / Relação Dose-Resposta a Droga / Hepatopatia Gordurosa não Alcoólica Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esteroides / Relação Dose-Resposta a Droga / Hepatopatia Gordurosa não Alcoólica Idioma: En Ano de publicação: 2022 Tipo de documento: Article